Clinical trial
Efficacy and Safety of Indoor Residual Spray for Dengue Vector Control
NCT07838701 is registered in ClinicalTrials.gov with Pak Emirates Military Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Indoor Residual Spray for Dengue Vector Control
- Lead sponsor
- Pak Emirates Military Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2024
- Completion date
- May 1, 2025
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.